Floatz logo

Fluzone

Breast Cancer Triple Negative

Rush University Medical CenterPhase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
95/ 100

Competitive context

3 Active assets in the Breast Cancer Triple Negative cohort.

Asset / SponsorPhaseRating
TIL
Essen Biotech
Phase 1/2CCC
Fluzone Quadrivalent
Rush University Medical Center
Phase 1CC

Same molecule, other indications

Fluzone is also rated in:

MELAS syndromeDormant
BB
Indicative ·
69 / 100
View asset →
Waldenstrom macroglobulinemiaDormant
B
Indicative ·
57 / 100
View asset →
influenzaDormant
B
Indicative ·
57 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →